Review of methods for measuring beta-cell function: Design considerations from the Restoring Insulin Secretion (RISE) Consortium

Publication Description
The Restoring Insulin Secretion (RISE) study was initiated to evaluate interventions to slow or reverse the progression of beta-cell failure in type 2 diabetes (T2D). To design the RISE study, we undertook an evaluation of methods for measurement of beta-cell function and changes in beta-cell function in response to interventions. In the present paper, we review approaches for measurement of beta-cell function, focusing on methodologic and feasibility considerations. Methodologic considerations included: (1) the utility of each technique for evaluating key aspects of beta-cell function (first- and second-phase insulin secretion, maximum insulin secretion, glucose sensitivity, incretin effects) and (2) tactics for incorporating a measurement of insulin sensitivity in order to adjust insulin secretion measures for insulin sensitivity appropriately. Of particular concern were the capacity to measure beta-cell function accurately in those with poor function, as is seen in established T2D, and the capacity of each method for demonstrating treatment-induced changes in beta-cell function. Feasibility considerations included: staff burden, including time and required methodological expertise; participant burden, including time and number of study visits; and ease of standardizing methods across a multicentre consortium. After this evaluation, we selected a 2-day measurement procedure, combining a 3-hour 75-g oral glucose tolerance test and a 2-stage hyperglycaemic clamp procedure, augmented with arginine.

Volume
20

Issue
1

Start Page
14

Other Pages
24

Author Address
Departments of Pediatrics (T. S. H.) and Medicine (K. J. M.), Indiana University School of Medicine, Indianapolis, Indiana.; VA Puget Sound Health Care System and Department of Medicine, University of Washington, Seattle, Washington.; VA Puget S(TRUNCATED)
Publication Date
1-Jan
Place of Publication
England
ISSN/ISBN
1463-1326
Document Object Index
10.1111/dom.13005 [doi]
Accession Number
PMID: 28493515
PMCID
PMC6095472
PMID
28493515
Primary Author
Hannon,T. S.
Kahn,S. E.
Utzschneider,K. M.
Buchanan,T. A.
Nadeau,K. J.
Zeitler,P. S.
Ehrmann,D. A.
Arslanian,S. A.
Caprio,S.
Edelstein,S. L.
Savage,P. J.
Mather,K. J.
RISE Consortium
Publisher
John Wiley & Sons Ltd

Reference Type
Journal Article

Periodical Full
Diabetes, obesity & metabolism

Publication Year
2018